WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
HK Stock Market Move | NEW VISION CO (02632) rose by over 17% in the afternoon, reaching a new high in stock price. The total market value is close to 11 billion Hong Kong dollars.
Huafu Securities: Independent car companies have long-term broad prospects for going overseas, and overseas sales are expected to reach over 9 million vehicles in the future.
HK Stock Market Move | Oil stocks collectively rise as the blockade of the Strait of Hormuz leads to energy supply interruptions. Institutions predict that short-term crude oil prices will remain strong.
HK Stock Market Move | NEW VISION CO (02632) rose by over 17% in the afternoon, reaching a new high in stock price. The total market value is close to 11 billion Hong Kong dollars.
Huafu Securities: Independent car companies have long-term broad prospects for going overseas, and overseas sales are expected to reach over 9 million vehicles in the future.
HK Stock Market Move | Oil stocks collectively rise as the blockade of the Strait of Hormuz leads to energy supply interruptions. Institutions predict that short-term crude oil prices will remain strong.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
